Diabetes 51:2877-2885, 2002
© 2002 by the American Diabetes Association, Inc.
Metabolic and Autocrine Regulation of the Mammalian Target of Rapamycin by Pancreatic ß-Cells
Michael L. McDaniel,
Connie A. Marshall,
Kirk L. Pappan, and
Guim Kwon
From the Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri
Mammalian target of rapamycin (mTOR) is a serine and threonine protein kinase that regulates numerous cellular functions, in particular, the initiation of protein translation. mTOR-mediated phosphorylation of both the translational repressor eukaryotic initiation factor 4E binding protein-1 and p70 S6 kinase are early events that control the translation initiation process. Rapamycin, an inhibitor of mTOR, is a potent immunosuppressant due, in part, to its ability to interfere with T-cell activation at the level of translation, and it has gained a prominent role in preventing the development and progression of rejection in pancreatic islet transplant recipients. The characterization of the insulin signaling cascade that modulates mTOR in insulin-sensitive tissues has been a major focus of investigation. Recently, the ability of nutrients, in particular the branched-chain amino acid leucine, to activate mTOR independent of insulin by a process designated as nutrient signaling has been identified. The ß-cell expresses components of the insulin signaling cascade and utilizes the metabolism of nutrients to affect insulin secretion. These combined transduction processes make the ß-cell an unique cell to study metabolic and autocrine regulation of mTOR signaling. Our studies have described the ability of insulin and IGFs in concert with the nutrients leucine, glutamine, and glucose to modulate protein translation through mTOR in ß-cells. These findings suggest that mitochondria-derived factors, ATP in particular, may be responsible for nutrient signaling. The significance of these findings is that the optimization of mitochondrial function is not only important for insulin secretion but may significantly impact the growth and proliferation of ß-cells through these mTOR signaling pathways.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. E. Gleason, D. Lu, L. A. Witters, C. B. Newgard, and M. J. Birnbaum
The Role of AMPK and mTOR in Nutrient Sensing in Pancreatic beta-Cells
J. Biol. Chem.,
April 6, 2007;
282(14):
10341 - 10351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Fernandez, M. A. Martin, S. Fajardo, F. Escriva, and C. Alvarez
Increased IRS-2 content and activation of IGF-I pathway contribute to enhance beta-cell mass in fetuses from undernourished pregnant rats
Am J Physiol Endocrinol Metab,
January 1, 2007;
292(1):
E187 - E195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Newsholme, L. Brennan, and K. Bender
Amino Acid Metabolism, {beta}-Cell Function, and Diabetes
Diabetes,
December 1, 2006;
55(Supplement_2):
S39 - S47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Martens, Q. Wang, K. Kerckhofs, G. Stange, Z. Ling, and D. Pipeleers
Metabolic Activation of Glucose Low-Responsive {beta}-Cells by Glyceraldehyde Correlates with Their Biosynthetic Activation in Lower Glucose Concentration Range But Not at High Glucose
Endocrinology,
November 1, 2006;
147(11):
5196 - 5204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kwon, C. A. Marshall, H. Liu, K. L. Pappan, M. S. Remedi, and M. L. McDaniel
Glucose-stimulated DNA Synthesis through Mammalian Target of Rapamycin (mTOR) Is Regulated by KATP Channels: EFFECTS ON CELL CYCLE PROGRESSION IN RODENT ISLETS
J. Biol. Chem.,
February 10, 2006;
281(6):
3261 - 3267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Briaud, L. M. Dickson, M. K. Lingohr, J. F. McCuaig, J. C. Lawrence, and C. J. Rhodes
Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in {beta}-Cells
J. Biol. Chem.,
January 21, 2005;
280(3):
2282 - 2293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kwon, C. A. Marshall, K. L. Pappan, M. S. Remedi, and M. L. McDaniel
Signaling Elements Involved in the Metabolic Regulation of mTOR by Nutrients, Incretins, and Growth Factors in Islets
Diabetes,
December 1, 2004;
53(suppl_3):
S225 - S232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Dickson and C. J. Rhodes
Pancreatic {beta}-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt?
Am J Physiol Endocrinol Metab,
August 1, 2004;
287(2):
E192 - E198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Andreozzi, C. D'Alessandris, M. Federici, E. Laratta, S. Del Guerra, S. Del Prato, P. Marchetti, R. Lauro, F. Perticone, and G. Sesti
Activation of the Hexosamine Pathway Leads to Phosphorylation of Insulin Receptor Substrate-1 on Ser307 and Ser612 and Impairs the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Insulin Biosynthetic Pathway in RIN Pancreatic {beta}-Cells
Endocrinology,
June 1, 2004;
145(6):
2845 - 2857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Drenan, X. Liu, P. G. Bertram, and X. F. S. Zheng
FKBP12-Rapamycin-associated Protein or Mammalian Target of Rapamycin (FRAP/mTOR) Localization in the Endoplasmic Reticulum and the Golgi Apparatus
J. Biol. Chem.,
January 2, 2004;
279(1):
772 - 778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Harris and J. C. Lawrence Jr.
TOR Signaling
Sci. Signal.,
December 9, 2003;
2003(212):
re15 - re15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wicksteed, C. Alarcon, I. Briaud, M. K. Lingohr, and C. J. Rhodes
Glucose-induced Translational Control of Proinsulin Biosynthesis Is Proportional to Preproinsulin mRNA Levels in Islet {beta}-Cells but Not Regulated via a Positive Feedback of Secreted Insulin
J. Biol. Chem.,
October 24, 2003;
278(43):
42080 - 42090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Lynch, B. Halle, H. Fujii, T. C. Vary, R. Wallin, Z. Damuni, and S. M. Hutson
Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR
Am J Physiol Endocrinol Metab,
October 1, 2003;
285(4):
E854 - E863.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|